UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
____________

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report  (Date of earliest event reported):
May 26, 2011

CREXUS INVESTMENT CORP. 
(Exact name of registrant as specified in its charter)
   

Maryland

1-34451

26-2652391

(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)

1211 Avenue of the Americas
Suite 2902

New York, New York

10036

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code:   (646) 829-0160  

No Change
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.07.  Submission of Matters to a Vote of Security Holders

On May 26, 2011, CreXus Investment Corp. (“CreXus” or the “Company”) held its Annual Meeting in New York, New York for the purpose of: (i) electing two Class II directors to serve on the Board until the 2014 Annual Meeting of Stockholders; (ii) approving of a non-binding advisory resolution on our executive compensation; (iii)  recommending, by a non-binding advisory vote, the frequency of advisory votes on the Company’s executive compensation; and (iv) ratifying the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2011.  The total number of shares of common stock entitled to vote at the Annual Meeting was 18,120,112, of which 16,728,326 shares, or 92.3%, were present in person or by proxy.

The final voting results for each of the proposals submitted to a vote of stockholders at the Annual Meeting are set forth below.

Proposal 1.   The election of two Class II directors to serve on the Board until the 2014 Annual Meeting of Stockholders.

Director

Votes Received Votes Withheld Broker Non-Votes
Kevin Riordan 12,915,520 1,132,746 2,680,060
Robert B. Eastep 12,933,931 1,114,335 2,680,060

All Class II director nominees were elected.  The continuing directors of the Company are Patrick Corcoran, Nancy Jo Kuestner and Ronald Kazel.

Proposal 2.  A vote on a non-binding advisory resolution on the Company’s executive compensation.

For Against Abstentions Broker Non-Votes
 
13,100,088 931,211 16,967 2,680,060

Proposal 3.  A vote on the recommendation, by a non-binding advisory vote, on the frequency of advisory votes on the Company’s executive compensation.

One Year Two Years Three Years Abstentions

Broker Non-Votes

 
6,331,464 1,907,272 5,790,493 19,037

2,680,060


Proposal 4.  Ratification of the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for the 2011 fiscal year.

For Against Abstentions
 
16,523,624 195,261 9,441

Further information regarding these proposals is set forth in CreXus’ definitive proxy statement on Schedule 14A filed with the SEC on April 11, 2011.


SIGNATURES

             Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CreXus Investment Corp.
 
 
By: /s/ Daniel Wickey

Name:  Daniel Wickey

Title:   Chief Financial Officer

 

Date: May 27, 2011